Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00RXR
|
|||
| Former ID |
DIB014379
|
|||
| Drug Name |
AC-253
|
|||
| Synonyms |
Antam; Amylin antagonist, Amylin; Amylin antagonist, Glaxo; GG-747
Click to Show/Hide
|
|||
| Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Discontinued in Phase 1 | [1] | |
| Company |
Amylin Pharmaceuticals Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Amylin receptor (IAPPR) | Target Info | Antagonist | [2] |
| KEGG Pathway | Vascular smooth muscle contraction | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001605) | |||
| REF 2 | Biotechnology and Its Application in Pharmacy. Kulkarn. 2002. Page157. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.